-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Public Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Public Health
- Code of Conduct
- Sustainability
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSScientific Poster
IQVIA Publications in ASCO20 Virtual Scientific Program
May 21, 2020
As the American Society of Oncology (ASCO) 2020 annual meeting moved to a virtual format, IQVIA’s oncology experts contributed to several publications across multiple topics and indications.
Featured Abstracts
What are the challenges for building real world comparative cohorts in oncology?
Abstract in ASCO20 Virtual Scientific Program: Health Services Research and Quality Improvement
IQVIA Authors
Nikita Jeswani, Amanda McDonell, Finlay MacDougall, Jeff Paul Hodge
Leveraging real world data and AIML to inform smart patient care in oncology
Abstract in ASCO20 Virtual Scientific Program: Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
IQVIA Authors
Li Zhou, Rob Steen, Lynn Lu
Patient trial matching using pseudo-siamese network
Abstract in ASCO20 Virtual Scientific Program: Care Delivery and Regulatory Policy
IQVIA Authors
Cao Xiao, Junyi Gao, Lucas Glass, Jimeng Sun
See below for more ASCO20 abstracts from IQVIA authors.
View Abstract
VIEW ABSTRACT
VIEW ABSTRACT
MSI/MMR test usage and checkpoint inhibitor practices in Europe.
Abstract in ASCO20 Virtual Scientific Program: Health Services Research and Quality Improvement
AUTHORS
Bradley Smith, Jeffrey Hodge, Caroline Anger, Fil Manuguid, Kriti Jindal; IQVIA, Marblehead, MA; IQVIA, Durham, NC; IQVIA, London, United Kingdom
View Abstract
Real-world clinical and economic burden associated with hospitalization in metastatic triple-negative (ER-/PR-/HER2-) breast cancer.
Abstract in ASCO20 Virtual Scientific Program: Health Services Research and Quality Improvement
AUTHORS
Amie Tan, Xu Han, Aimee Near, Jenny Tse, Luciana Preger; Genentech, Inc., South San Francisco, CA; IQVIA, Durham, NC
VIEW ABSTRACT
Trends in immunotherapy use in patients with advanced non-small cell lung cancer (aNSCLC) patients: Analysis of real-world data.
Abstract in ASCO20 Virtual Scientific Program: Health Services Research and Quality Improvement
AUTHORS
Lawrence H. Kushi, Laura Lasiter, Andrew J. Belli, Marley Boyd, Suanna S. Bruinooge, Jennifer Christian, Elizabeth Garrett-Mayer, Eric Hansen, Rebecca Honnold, Ruth Pe Benito, Yanina Natanzon, Lori Sakoda, Donna R. R Rivera, Whitney Rhodes, Nicholas J. Robert, Elad Sharon, Connor Sweetnam, Joseph Wagner, Mark S. Walker, Jeff Allen; Kaiser Permanente, Oakland, CA; Friends of Cancer Research, Washington, DC; COTA, Inc., New York, NY; McKesson Life Sciences, The Woodlands, TX; American Society of Clinical Oncology, Alexandria, VA; IQVIA, Research Triangle Park, NC; Tempus Labs, Chicago; Tempus, Chicago, IL; Syapse, San Francisco, CA; Kaiser Permanente Northern California, Division of Research, Oakland, CA; National Cancer Institute, Rockville, MD; Concerto HealthAI, Memphis, TN; 10101 Woodloch Forest, The Woodlands, TX; National Cancer Institute, Bethesda, MD; Syapse Inc., San Francisco, CA; IQVIA, Plymouth Meeting, PA; ACORN Research LLC, Memphis, TN
VIEW ABSTRACT
Overall survival (OS) in advanced non-small cell lung cancer (aNSCLC) patients treated with frontline chemotherapy or immunotherapy by comorbidity: A real-world data (RWD) collaboration.
Abstract in ASCO20 Virtual Scientific Program: Health Services Research and Quality Improvement
AUTHOR(S)
Donna R. R Rivera, Laura Lasiter, Jennifer Christian, Lindsey Enewold, Janet L. Espirito, Eric Hansen, Henry J. Henk, Lawrence H. Kushi, Daniel Lane, Yanina Natanzon, Ruth Pe Benito, Erik Rasmussen, Nicholas J. Robert, Mark Stewart, Connor Sweetnam, Olga Tymejczyk, Emily Valice, Joseph Wagner, Alia Zander, Jeff Allen; National Cancer Institute, Rockville, MD; Friends of Cancer Research, Washington, DC; IQVIA, Research Triangle Park, NC; National Cancer Institute, Bethesda, MD; McKesson Life Sciences, The Woodlands, TX; COTA, Inc., New York, NY; OptumLabs, Shakopee, MN; Kaiser Permanente, Oakland, CA; COTA Healthcare, Boston, MA; Syapse, San Francisco, CA; Tempus, Chicago, IL; Flatiron Health, New York, NY; 10101 Woodloch Forest, The Woodlands, TX; Syapse Inc., San Francisco, CA; Kaiser Permanente Division of Research, Oakland, CA; IQVIA, Plymouth Meeting, PA
VIEW ABSTRACT
Adverse event and outcome patterns in patients with advanced multiple myeloma in the United States.
Abstract in ASCO20 Virtual Scientific Program: Hematologic Malignancies—Plasma Cell Dyscrasia
AUTHORS
Joshua Ryan Richter, Jason Yeaw, Drishti Shah, Ruthwik Anupindi, Suneel Kudaravalli, Stojan Zavisic; The Tisch Cancer Institute/Icahn School of Medicine at Mount Sinai, New York, NY; IQVIA, San Francisco; IQVIA, Falls Church, VA; Oncopeptides, Mountain View, CA; Oncopeptides AB, Stockholm, Sweden
VIEW ABSTRACT
Burden of relapsed/refractory (RR) acute myeloid leukemia.
Abstract in ASCO20 Virtual Scientific Program: Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
AUTHORS
Sumeet Panjabi, Dionne M. Hines, Catherine Balderston McGuiness, Emre Yucel, Steven Yea, Zachariah McIver, Rolin L Wade; Amgen, Inc., South San Francisco, CA; IQVIA, Plymouth Meeting, PA; Amgen, Inc, Thousand Oaks, CA
VIEW ABSTRACT
A retrospective analysis of CDK4/6 inhibitors among adult female patients with metastatic breast cancer.
Abstract in ASCO20 Virtual Scientific Program: Breast Cancer—Metastatic
AUTHORS
Silvia Comis, Thenmozhi Kandasamy, Alysa J Perrin, Kelley Kent, Mahendra Dulawat, Arun Chhikara, Nitish Ranjan; IQVIA, Milan, Italy; IQVIA, Inc., Durham, NC
VIEW ABSTRACT
Prognostic factors impacting survival in early HER2-positive breast cancer (BC): Results from a 1,142 patients database study.
Abstract in ASCO20 Virtual Scientific Program: Breast Cancer - Local/Regional/Adjuvant
AUTHORS
Roberto Hegg, Andre Mattar, Maurício Rocha, Renato Watanabe Oliveira, Guilherme Silva Julian, Luiz Henrique Gebrim; Hospital Pérola Byington, São Paulo, Brazil; Roche Brazil, São Paulo, Brazil; IQVIA, São Paulo, Brazil
VIEW ABSTRACT
Comparative effectiveness of immune-checkpoint inhibitors as first-line treatment for advanced nonsquamous non-small cell lung cancer patients: A network meta-analysis and a systematic review.
Abstract in ASCO20 Virtual Scientific Program: Lung Cancer—Non-Small Cell Metastatic
AUTHORS
Roberto Jorge Bitton, Natalia Jacob, Juan Manuel Carrera, Ezequiel Cayetano Perez; IQVIA, Buenos Aires, Argentina; Quintiles, Buenos Aires, Argentina